Investors: High-Tech Grunderfonds (https://www.htgf.de/en/) Quantonation (http://www.quantonation.com/) Runa Capital (http://www.runacap.com/) SIT Capital (https://sit.capital/#about-us) Verve Ventures (http://verve.vc/) Zürcher Kantonal Bank (https://www.zkb.ch/)
Invizius secures GBP5.3m in Series A financing round
HQ: UK
Founded: 2018
Series A
Sector: BioTech
Investment Raised: GBP 5.3M €
Valuation Remains Undisclosed
Investors: Calculus Capital (http://www.calculuscapital.com/) Downing Ventures (https://www.downing.co.uk/) Jonathan Milner Mercia Fund Managers (https://www.mercia.co.uk/) Old College Capital (http://www.oldcollegecapital.com/) Scottish Enterprise (http://www.scottish-enterprise.com/) Solvay Ventures (https://www.solvay.com/en/)
Investors: Bay City Capital (http://www.baycitycapital.com/) Brunnur Ventures (http://www.brunnurventures.com/) BVCF (http://www.bvcf.com/) Earlybird Venture Capital (http://earlybird.com/) Hyfinity Investments (http://www.hyfinityfund.com/) Nan Fung Life Sciences (https://www.nanfunglifesciences.com/) Novartis Venture Fund (http://www.nvfund.com/) Pivotal bioVenture Partners (https://pivotalbiovp.com/) Silfurberg (http://www.silfurberg.is/) Tekla Capital Management (http://teklacap.com/) VI Partners (http://www.vipartners.ch/) Wille Finance (https://www.willefinance.com/)
OLGRAM Completes a €1.5m Seed Round With Business Angels, Bpifrance And the Brittany Region to Accelerate the Development of a New First in Class Anti-infectious Molecules Extracted From an Algae
Monte Rosa Therapeutics Raises $95M in Series C Financing
HQ: CH
Founded: 2018
Series C
Sector: BioTech, Therapeutics
Investment Raised: USD 95M €
Valuation Remains Undisclosed
Investors: Versant Ventures (https://www.versantventures.com/) Sixty Degree Capital (https://www.sixtydegreecapital.com/) New Enterprise Associates (http://www.nea.com/) HBM Healthcare Investments AG (http://www.hbmhealthcare.com/) Fidelity Management and Research Company (https://www.fidelity.com/) Cormorant Asset Management (https://www.crunchbase.com/organization/cormorant-asset-management) Casdin Capital (http://www.casdincapital.com/) Cambridge Asset Management Avoro Capital Advisors (https://avorocapital.com/) Amzak Health Investors and Aisling Capital
Investors: Triventures (http://www.triventures.net/) Rimonci Capital Pontifax (http://www.pontifax.com/) Global health sciences venture fund Diamond BioFund (http://www.diamondcapital.com.tw/) CR-CP Life Science Fund and BPC Investments
Investors: SFINE (http://www.sfine.fr/) Paris Business Angels (http://parisbusinessangels.com/) Normandie Business Angels (http://www.normandieba.com/) Business Angels des Grandes Ecoles and Angels Santé
Investors: Pitango Venture Capital (http://www.pitango.com/) New Era Capital Partners (https://www.neweracp.com/) IBM Ventures (https://www.ibm.com/at-de) Global health sciences venture fund and 20/20 HealthCare Partners (http://www.2020hcp.com/)
Investors: SKS PE Daishin Private Equity (https://www.daishin.com/) SKS PE InterVest (http://intervest.co.kr/en) KDB Bank (http://www.kdbbank.eu/) Asset One Kakao Ventures (http://www.medium.com/kakaoventures) LB Investment (http://lbinvestment.com/) Atinum Investment (http://www.atinuminvest.co.kr/) DSC Investment and Wonik Investment Partners.
Beam raises $80 million for AI-driven dental coverage that rewards good hygiene
HQ: US
Founded: 2012
Series E
Sector: AI, BioTech, Dental
Investment Raised: USD 80M €
Valuation Remains Undisclosed
Investors: Mercato Partners (https://mercatopartners.com/) Traverse Fund (https://traverse.mercatopartners.com/) Nationwide Insurance (https://www.nationwide.com/) Georgian Drive Capital and Breakout Capital.
Tenaya Therapeutics Raises $106M in Series C Funding
HQ: US
Founded: 2016
Series C
Sector: BioTech
Investment Raised: USD 106M €
Valuation Remains Undisclosed
Investors: RTW Investments LLC (https://www.rtwfunds.com/) T. Rowe Price (https://www.troweprice.com/corporate/us/en/home.html) The Column Group (https://www.thecolumngroup.com/) RA Capital Management (https://www.racap.com/) Fidelity Management and Casdin Capital
ABclonal Biotechnology Closes USD 93M Series C Financing
HQ: US
Founded: 2011
Series C
Sector: BioTech
Investment Raised: USD 93M €
Valuation Remains Undisclosed
Investors: Sequoia Capital China (https://www.sequoiacap.cn/china/) LYFE Capital (http://www.lyfecapital.com/) participation from Sigma Square Capital Kinghall Ventures Lucion Capital Volition Capital (https://www.volitioncapital.com/)
